Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Duloxetine-Induced Nocturnal Bruxism Resolved by Buspirone: Case Report

Albayrak, Yakup MD*; Ekinci, Okan MD

doi: 10.1097/WNF.0b013e3182227736
Case Reports

Duloxetine is a serotonin-norepinephrine reuptake inhibitor which is generally safe and well tolerated. Antidepressants especially selective serotonin reuptake inhibitors (SSRIs) were associated with inducing bruxism; however, duloxetine-induced bruxism has not been reported yet. Here, we report a case of duloxetine-induced bruxism in a patient with generalized anxiety disorder.

*Department of Psychiatry, Gölbaşı Havsak State Hospital, Ankara; and †Department of Psychiatry, Yozgat State Hospital, Yozgat, Turkey.

Address correspondence and reprint requests to Yakup Albayrak, MD, Gölbaşı Havsak Devlet Hastanesi Psikiyatri Klinigi, 06520, Gölbaşı, Ankara, Turkey; E-mail:

Conflicts of Interest and Source of Funding: The authors have no conflicts of interest to declare.

© 2011 Lippincott Williams & Wilkins, Inc.